GenScript Strives for Research Excellence Amidst the Global COVID-19 Pandemic
Piscataway, New Jersey, March 20, 2020 – As the coronavirus (COVID-19) pandemic continues to evolve globally, many of us have been inevitably impacted in our daily life. At this unprecedented moment, filled with challenges and uncertainty, we would like you to know that GenScript is firmly committed to serving our clients, the research and healthcare community, and anyone in need of us, to the best of our abilities. We want you to know that you can rely on us and expect undisrupted services and products with the same quality standards.
During this time, we have placed the health and safety of our employees as the first and foremost priority. We have taken active precautionary measures to safeguard their well-being by means including but not limited to: enabling remote work for employees whose functions can be performed off-site; implementing stringent safety protocols on site; professionally disinfecting our offices, laboratories, warehouses, as well as inbound and outbound packages to minimize the transmission of virus. We extend our sincere thanks to our employees worldwide who keep our business running smoothly.
As a multinational corporation, GenScript has also established a complete and stable business infrastructure, and have implemented a business continuity plan which examines all areas of business operations. These plans enable us to sustain and thrive through different adverse circumstances. At this time, we are glad to let you know that GenScript’s production facilities are operating at full capacity and we anticipate minimum delays, if any, in project delivery across the globe. We are well prepared to receive new project requests from our customers. Our sales & technical support teams are fully equipped with virtual tools to conduct effective online communications and project discussions, available 24 hours from Monday to Friday. Our project managers are dedicated to provide you timely project updates and progress communication to ensure your research continues without disruption. Our shipment center can accommodate special shipping arrangements in case of temporary site closures.
With making human and nature healthier being our all-time mission, GenScript stands in the front line of combatting devastating diseases. In the past we have supported numerous scientists and researchers engaged in infectious disease research, including HIV, H7N9, H1N1, Ebola virus, Zika virus, etc. At this moment, we fully support and prioritize COVID-19-related research around the world. Additionally, utilizing our state-of-art technical platforms, we have developed a comprehensive panel of COVID-19 related services and products for both detection and treatment purposes, in an effort to accelerate a path towards a cure.
On behalf of GenScript Group Corporate, I want to thank you for putting your trust in us. We are committed to working through this challenging moment with you, and are confident that we will become an even stronger community together.
Chief Executive Officer